July 30th earnings... make sure you own PUTS. What are the near term drugs in 2013 to get MRK to $60? And dont say suvorexant thats already priced in. The fact is you can't becasue there is no news that can push the stock 5 points.
60? Current price is $47.5 ($46 after earnings July 30th) and has a 3 year high of $50. Any partnership is worth a 2 point increase at best. $50 is not in the cards for 2013 and 2014 and $60 is a total fantasy.